drugset / Trial / NCT03513770

Autonomic Control of the Circulation and VDR

NCT03513770

RandomizedCrossoverTriple-blindBasic science

Summary

The study objective of this project is to examine the mechanisms of the venous distension reflex (VDR) in humans. We hypothesize that COX blockade with ketorolac tromethamine, an intravenous NSAID, will attenuate the muscle sympathetic nerve activity (MSNA) response to limb venous distension. To gain further insight into whether the COX byproducts directly stimulate chemically-sensitive afferents, or enable venodilation and indirectly evoke afferent stimulation, we will measure vein size using 3T MRI during venous distention with and without ketorolac infusions.

Timeline

Start
2019-08-14
Primary completion
2026-11-01
Completion
2027-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Tromethamine Small molecule 3 mg Intravenous
Subject Ketorolac Tromethamine Small molecule 6 mg Intravenous

Indications

No indication recorded.